{"id":61543,"title":"Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL.","abstract":"","date":"2014-06-13","categories":"Hemic and Lymphatic Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24705492","annotations":[{"name":"Disease","weight":0.705743,"wikipedia_article":"http://en.wikipedia.org/wiki/Disease"},{"name":"Bone marrow","weight":0.346942,"wikipedia_article":"http://en.wikipedia.org/wiki/Bone_marrow"},{"name":"Therapy","weight":0.310706,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Bone","weight":0.0546925,"wikipedia_article":"http://en.wikipedia.org/wiki/Bone"},{"name":"Discontinuation","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Discontinuation"},{"name":"Residue (chemistry)","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Residue_(chemistry)"},{"name":"Eradication of infectious diseases","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Eradication_of_infectious_diseases"},{"name":"B-cell chronic lymphocytic leukemia","weight":0.0157947,"wikipedia_article":"http://en.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia"}]}
